This combination of effects is what makes GLP-1 therapies useful for blood sugar control and weight loss, and may also explain why researchers are now exploring their impact in other areas
Ethel Ibaez has received fees as a speaker and consultant from Takeda, CSL Behring, and Biocryst
Depending on how appetite, hydration, digestion, and food intake change over time, certain nutrient deficiencies may become more likely to develop, making certain nutrients harder to maintain consistently through meals alone
Due to limited research, the roles of GPx5, GPx6, and GPx8 in tumorigenesis are still awaiting clarification
For patients who need both Toujeo specifically (the U-300 concentration) and a GLP-1 agonist, separate injections are currently the only option, as there is no combination product using the U-300 concentration
1 and reviewed below